Anmelden Kostenlos registrieren

180 Life Sciences 1-Jahres-Ziel

Was ist das 1-Jahres-Ziel von 180 Life Sciences?

1-Jahres-Ziel von 180 Life Sciences Corp. ist $4 +127.27%

Was ist die Definition von 1-Jahres-Ziel?

1-Jahres-Ziel ist ein prognostizierter Aktienkurs pro Jahr.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1-Jahres-Ziel von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu 180 Life Sciences

Was macht 180 Life Sciences?

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Unternehmen mit 1-jahres-ziel ähnlich 180 Life Sciences